Drug intelligence / Profile preview

LEAG

Development stage
Unknown
Lead developer
Southern Illinois University
Modality
Small Molecules
Administration
Oral
01

Overview

LEAG is a standardized, lyophilized water-extract of American ginseng (*Panax quinquefolium*) root, developed by Southern Illinois University for the treatment of breast cancer. Formulated as 250-mg gelatin capsules, it is being evaluated in Phase II clinical trials to assess its impact on tumor biomarkers and inflammatory mediators in patients prior to surgery. The therapeutic effect is attributed to its ability to modulate key inflammatory pathways, specifically by reducing the expression of cyclooxygenase-2 (COX-2) and inhibiting the activation of the p65 subunit of nuclear factor-kappa B (NF-κB). The preparation is certified for ginsenoside content and purity, representing a botanical approach to targeting the inflammatory microenvironment of breast tumors.

Other names
American ginseng root extractPanax quinquefolium root extractLyophilized extract of American ginseng
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)RELA (Nuclear Factor Kappa B Subunit p65)

Beyond the preview

Go deeper on LEAG.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LEAG.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call